ArticleBMC pediatrics2025
Outcomes of neonatal hyperbilirubinemia and associated factors at a tertiary hospital in Ghana.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Study to correlate the parental judgement of neonatal jaundice using clinical and biochemical profile.Bioinformation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNeonatal Hyperbilirubinemia (NH) is one of the most common clinical presentations in the first week of life.
aimsThis study sought to determine the incidence, clinical presentation and risk factors associated with mortality, among neonates presenting with unconjugated NH at the Komfo Anokye Teaching Hospital in Ghana. METHODOLOGY: This was a hospital-based prospective analytical cohort study conducted from October to December 2020. A total of 223 newborns admitted to the nursery with NH were recruited, mothers were interviewed, and patients were followed-up until discharge. Data was collected and analyzed with R statistical software. Associations were determined as crude and adjusted odds ratios using univariate and multivariate binomial logistic regression.
resultsThe incidence of NH was 244 per 1000 admissions (95% CI: 21.7-27.3) with a case fatality rate of 8.1% (95% CI: 4.8-12.4). Independent predictors of increased mortality were older age at admission [AOR = 1.28(1.05-1.57), p = 0.015], gestational age between 35 and 37 weeks [AOR = 4.89(1.04-25.8), p = 0.047], and the presence of abnormal posture at admission [AOR = 6.40(1.37-35.9), p = 0.023]. The presentations associated with survival till discharge were primiparity in the mother [AOR = 0.06(0.01, 0.32), p = 0.003], and exclusive breastfeeding at the time of admission [AOR = 0.09 (0.02-0.46), p = 0.004].
conclusionThe incidence of hyperbilirubinemia among neonates admitted to the Mother Baby Unit at KATH is high and gestational ages between 35 and 37 weeks, abnormal posture and older age at presentation were identified to be significantly associated with mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.